Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_assertion type Assertion NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_head.
- NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_assertion description "[Currently prostate-specific membrane antigen (PSMA) is showing promise both as an imaging and therapeutic target for occult prostate cancer metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_provenance.
- NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_assertion evidence source_evidence_literature NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_provenance.
- NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_assertion SIO_000772 14716746 NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_provenance.
- NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_assertion wasDerivedFrom befree-20140225 NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_provenance.
- NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_assertion wasGeneratedBy ECO_0000203 NP763359.RA3jaTGNsZlrJMkLNY_bwU3s9wMKJ9tfxRsQiltNi922I130_provenance.